Atlas Trials

Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer

Clinical trial NCT07562659 · RECRUITING

Trial details

NCT number
NCT07562659
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ctDNAColorectal Cancer (CRC)Adjuvant Chemotherapy
Start date
2024-11-01
Primary completion
2027-12-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.